Cochlear Implants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report Download FREE Resources

Published: May 10, 2024 Report Code: GDME1740EPD-ST

Select Item

Cochlear Implants Pipeline Market Report Overview

A cochlear implant (CI) bionic ear is a device that can be surgically implanted into a person’s cochlea to stimulate it to enhance or restore hearing. The cochlear implants pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       The US

·       Europe

·       Finland

·       France

·       Austria
Key Regulatory Paths ·       PMA

·       CE

·       510(K)
Leading Companies ·       Advanced Bionics AG

·       Advanced Bionics LLC

·       Auritec Pharmaceuticals Inc

·       Ceragenix Pharmaceuticals, Inc. (Inactive)

·       Cochlear Ltd
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Cochlear Implants Pipeline Market Segmentation by Territories

A few of the key territories with the cochlear implants pipeline market are the US, Europe, Finland, France, and Austria. As of May 2024, the US accounts for the highest number of cochlear implant pipeline products.

Cochlear Implants Pipeline Market Analysis by Territories, 2024 (%)

Cochlear Implants Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Cochlear Implants Pipeline Market

Download a Free Report Sample

Cochlear Implants Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the cochlear implants pipeline products market are PMA, CE, and 510(k). As of May 2024, PMA is the most followed pathway for pipeline products in the cochlear implants market.

Cochlear Implants Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Cochlear Implants Pipeline Market Analysis by Regulatory Paths, 2024 (%)Buy the Full Report for More Regulatory Path Insights into the Cochlear Implants Pipeline Market

Download a Free Report Sample

Cochlear Implants Pipeline Market – Competitive Landscape

A few of the key companies associated with the cochlear implants pipeline market are Advanced Bionics AG, Advanced Bionics LLC, Auritec Pharmaceuticals Inc., Ceragenix Pharmaceuticals, Inc. (Inactive), and Cochlear Ltd among others.

Advanced Bionics AG: Advanced Bionics AG (Advanced Bionics) develops, manufactures, and markets cochlear implant systems and hearing care solutions. Advanced Bionics is headquartered in Stafa, Zurich, Switzerland.

Advanced Bionics LLC: Advanced Bionics LLC (Advanced Bionics), a subsidiary of Sonova Holding AG, is a medical device company that develops, manufactures, and markets cochlear implant systems. The company’s medical devices are used to restore the sense of hearing. It provides sound processors and accessories. Advanced Bionics offers products for audiology, surgical, library, product development, education and training, and clinical research support. It provides a range of wireless technologies for streaming audio. The company has operations in Switzerland, Brazil, Australia, Belgium, Colombia, China, Denmark, France, Hong Kong, the US, India, and Italy, among others. Advanced Bionics is headquartered in Valencia, California, the US.

Cochlear Implants Pipeline Market Analysis by Companies, 2024

Cochlear Implants Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Cochlear Implants Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Cochlear Implants Pipeline Market Territories Outlook (2024)

  • The US
  • Europe
  • Finland
  • France
  • Austria

Cochlear Implants Pipeline Market Regulatory Paths Outlook (2024)

  • PMA
  • CE
  • 510(K)

Scope

This report provides:

  • Extensive coverage of the cochlear implants under development.

  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.

  • Reviews of major players involved in the development of cochlear implants and lists all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of cochlear implants under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Advanced Bionics AG
Advanced Bionics LLC
Auritec Pharmaceuticals Inc
Ceragenix Pharmaceuticals, Inc. (Inactive)
Cochlear Ltd
Demant A/S
Hannover Medical School
Huntington Medical Research Institutes
Labyrinth Devices
MED-EL Elektromedizinische Gerate Gesellschaft mbH
Naval Information Warfare Center Pacific
Northwestern University
OtoKinetics Inc
Sonova Holding AG
Tel Aviv Sourasky Medical Center
Trinity College Dublin
University of Michigan Pediatric Device Consortium
University of Utah
University of Wisconsin Madison

Table of Contents

  • Table of Contents

    • 1.1. List of Tables

    • 1.2. List of Figures

  • 2. Introduction

    • 2.1. Cochlear Implants Overview

  • 3. Products under Development

    • 3.1. Cochlear Implants – Pipeline Products by Stage of Development

    • 3.2. Cochlear Implants – Pipeline Products by Segment

    • 3.3. Cochlear Implants – Pipeline Products by Territory

    • 3.4. Cochlear Implants – Pipeline Products by Regulatory Path

    • 3.5. Cochlear Implants – Pipeline Products by Estimated Approval Date

    • 3.6. Cochlear Implants – Ongoing Clinical Trials

  • 4. Cochlear Implants – Pipeline Products under Development by Companies

    • 4.1. Cochlear Implants Companies – Pipeline Products by Stage of Development

    • 4.2. Cochlear Implants – Pipeline Products by Stage of Development

  • 5. Cochlear Implants Companies and Product Overview

    • 5.1. Advanced Bionics AG Company Overview

      • 5.1.1. Advanced Bionics AG Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2. Advanced Bionics LLC Company Overview

      • 5.2.1. Advanced Bionics LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3. Auritec Pharmaceuticals Inc. Company Overview

      • 5.3.1. Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4. Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview

      • 5.4.1. Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5. Cochlear Ltd Company Overview

      • 5.5.1. Cochlear Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6. Demant A/S Company Overview

      • 5.6.1. Demant A/S Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7. Hannover Medical School Company Overview

      • 5.7.1. Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8. Huntington Medical Research Institutes Company Overview

      • 5.8.1. Huntington Medical Research Institutes Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9. Labyrinth Devices Company Overview

      • 5.9.1. Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10. MED-EL Elektromedizinische Gerate Gesellschaft mbH Company Overview

      • 5.10.1. MED-EL Elektromedizinische Gerate Gesellschaft mbH Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11. Naval Information Warfare Center Pacific Company Overview

      • 5.11.1. Naval Information Warfare Center Pacific Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12. Northwestern University Company Overview

      • 5.12.1. Northwestern University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13. OtoKinetics Inc. Company Overview

      • 5.13.1. OtoKinetics Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14. Sonova Holding AG Company Overview

      • 5.14.1. Sonova Holding AG Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15. Tel Aviv Sourasky Medical Center Company Overview

      • 5.15.1. Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16. Trinity College Dublin Company Overview

      • 5.16.1. Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17. University of Michigan Pediatric Device Consortium Company Overview

      • 5.17.1. University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18. University of Utah Company Overview

      • 5.18.1. University of Utah Pipeline Products & Ongoing Clinical Trials Overview

    • 5.19. University of Wisconsin Madison Company Overview

      • 5.19.1. University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview

  • 6. Cochlear Implants- Recent Developments

    • 6.1. May 07, 2024: Sonova Announces Management Board Succession

    • 6.2. Feb 07, 2024: Sonova Opens New Operations Facility Serving Americas Region

    • 6.3. Dec 04, 2023: Advanced Bionics Extends Marvel CI Product Offering with Remote Programming and Expanded Linked Two-Ear Solutions

    • 6.4. Nov 21, 2023: Sonova Holding: First Half Results 2023/24

    • 6.5. Aug 24, 2023: Envoy Medical Appoints David R. Wells as Chief Financial Officer

  • 7. Appendix

    • 7.1. Methodology

    • 7.2. About GlobalData

    • 7.3. Contact Us

    • 7.4. Disclaimer

Table

Cochlear Implants – Pipeline Products by Stage of Development 9

Cochlear Implants – Pipeline Products by Segment 10

Cochlear Implants – Pipeline Products by Territory 11

Cochlear Implants – Pipeline Products by Regulatory Path 12

Cochlear Implants – Pipeline Products by Estimated Approval Date 13

Cochlear Implants – Ongoing Clinical Trials 14

Cochlear Implants Companies – Pipeline Products by Stage of Development 15

Cochlear Implants – Pipeline Products by Stage of Development 16

Advanced Bionics AG Pipeline Products & Ongoing Clinical Trials Overview 17

Naida CI Marvel Sound Processor – Product Status 17

Naida CI Marvel Sound Processor – Product Description 17

Advanced Bionics LLC Pipeline Products & Ongoing Clinical Trials Overview 18

Hires Fidelity 120 Pediatrics – Product Status 18

Hires Fidelity 120 Pediatrics – Product Description 18

Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Steroid Eluting Cochlear Implant – Product Status 19

Steroid Eluting Cochlear Implant – Product Description 19

Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 20

Cerashield Coated Cochlear Inner Ear Implant – Product Status 20

Cerashield Coated Cochlear Inner Ear Implant – Product Description 20

Cochlear Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

Nucleus Profile Plus – Product Status 21

Nucleus Profile Plus – Product Description 21

Demant A/S Pipeline Products & Ongoing Clinical Trials Overview 22

Neuro 2 – Product Status 22

Neuro 2 – Product Description 22

Demant A/S – Ongoing Clinical Trials Overview 23

Neuro 2 – Pupillometry Techniques Usage to Quantify the Programming Parameters Effect in the Auditory Effort in Zti Opticon Cochlear Implant Adult Users 24

Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 25

Optical Cochlea Stimulator – Product Status 25

Optical Cochlea Stimulator – Product Description 25

Huntington Medical Research Institutes Pipeline Products & Ongoing Clinical Trials Overview 26

Multisite Device – Product Status 26

Multisite Device – Product Description 26

Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview 27

MVI Vestibular Implant System – Product Status 27

MVI Vestibular Implant System – Product Description 27

Labyrinth Devices – Ongoing Clinical Trials Overview 28

MVI Vestibular Implant System – First-in-human Early Feasibility Study of Safety, Tolerability and Efficacy for a Multichannel Vestibular Implant in Individuals with Bilateral Severe-to-profound Loss of Vestibular Sensation 29

MVI Vestibular Implant System – Vestibular Implantation in Older Adults 29

MVI Vestibular Implant System – Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction 29

MED-EL Elektromedizinische Gerate Gesellschaft mbH Pipeline Products & Ongoing Clinical Trials Overview 30

Totally Implantable Cochlear Implant (TICI) – Product Status 30

Totally Implantable Cochlear Implant (TICI) – Product Description 30

Naval Information Warfare Center Pacific Pipeline Products & Ongoing Clinical Trials Overview 31

Bionic Cochlea Implant – Product Status 31

Bionic Cochlea Implant – Product Description 31

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 32

Cochlear Implant – Product Status 32

Cochlear Implant – Product Description 32

OtoKinetics Inc Pipeline Products & Ongoing Clinical Trials Overview 33

Krescendo I – Product Status 33

Krescendo I – Product Description 33

Sonova Holding AG Pipeline Products & Ongoing Clinical Trials Overview 34

Next Generation Cochlear Implant – Product Status 34

Next Generation Cochlear Implant – Product Description 34

Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 35

Implant Electrode Extender – Product Status 35

Implant Electrode Extender – Product Description 35

Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 36

Closed-loop Cochlear Implant – Product Status 36

Closed-loop Cochlear Implant – Product Description 36

University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 37

Enhanced Cochlear Implant Device – Product Status 37

Enhanced Cochlear Implant Device – Product Description 37

University of Utah Pipeline Products & Ongoing Clinical Trials Overview 38

Microphone Cochlear Implant – Product Status 38

Microphone Cochlear Implant – Product Description 38

University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 39

Cochlear Implant – Product Status 39

Cochlear Implant – Product Description 39

Glossary 49

Figures

Cochlear Implants – Pipeline Products by Stage of Development 9

Cochlear Implants – Pipeline Products by Segment 10

Cochlear Implants – Pipeline Products by Territory 11

Cochlear Implants – Pipeline Products by Regulatory Path 12

Cochlear Implants – Pipeline Products by Estimated Approval Date 13

Cochlear Implants – Ongoing Clinical Trials 14

Frequently asked questions

Cochlear Implants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Cochlear Implants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Cochlear Implants reports
Medical Devices
New
Neurovascular Accessory Devices Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | June 2026
Medical Devices
New
Neurovascular Embolization Devices Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | June 2026
Medical Devices
New
Sutures Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and…
$7,500 | June 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Cochlear Implants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Cochlear Implants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more